Brief Report: Weight Gain Following ART Initiation in ART-Naïve People Living With HIV in the Current Treatment Era

Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy

(2020) Jordan E Lake et al.   CLINICAL INFECTIOUS DISEASES

Greater Weight Gain in Treatment Naïve Persons Starting Dolutegravir-Based Antiretroviral Therapy

(2019) Kassem Bourgi et al.   CLINICAL INFECTIOUS DISEASES

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis

(2019) Maximilian Huhn et al.   LANCET

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

(2019) Willem D.F. Venter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients

(2019) Sebastiano Rizzardo et al.   AIDS

Incidence and Risk Factors for Prediabetes and Diabetes Mellitus Among HIV-infected Adults on Antiretroviral Therapy

(2018) Jobert Richie Nansseu et al.   EPIDEMIOLOGY

Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors

(2018) David R Bakal et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015

(2018) Robin M. Nance et al.   ANNALS OF INTERNAL MEDICINE

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

(2018) Michael S. Saag et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Progressive increases in fat mass occur in adults living with HIV on antiretroviral therapy, but patterns differ by sex and anatomic depot

(2018) Paula Debroy et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Impact of Weight Gain During HIV Treatment on Risk of Pre-diabetes, Diabetes Mellitus, Cardiovascular Disease, and Mortality

(2018) Shejil Kumar et al.   Frontiers in Endocrinology

Brief Report

(2017) Jamison Norwood et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

The triumph of HIV treatment: another new antiretroviral

(2017) Marta Boffito et al.   LANCET

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

(2017) Paul E Sax et al.   LANCET

Long-term body composition changes in antiretroviral-treated HIV-infected individuals

(2016) Philip M. Grant et al.   AIDS

Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada

(2016) John R. Koethe et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Higher Time-Updated Body Mass Index

(2016) John R. Koethe et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy

(2016) Josep M. Llibre et al.   PLoS One

The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy

(2015) John R. Koethe et al.   AIDS

Weight Change After Antiretroviral Therapy and Mortality

(2015) B. Yuh et al.   CLINICAL INFECTIOUS DISEASES

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

(2013) Francois Raffi et al.   LANCET

Short Communication: From Wasting to Obesity: Initial Antiretroviral Therapy and Weight Gain in HIV-Infected Persons

(2012) Wanda Lakey et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

HIV infection and obesity: where did all the wasting go?

(2012) Tyler Tate et al.   ANTIVIRAL THERAPY

Raltegravir: The First HIV Type 1 Integrase Inhibitor

(2009) Charles Hicks et al.   CLINICAL INFECTIOUS DISEASES

Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy

(2008) HM Crane et al.   HIV MEDICINE

Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems

(2008) M. M Kitahata et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY